Cognition Therapeutics stock forecast
Want to see CGTX full AI Analyst Report?
Cognition Therapeutics (CGTX) Stock Forecast & Price Target
CGTX Analyst Ratings
CGTX Stock 12 Month Forecast
Average Price Target
$3.00▲(341.83% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ram Selvaraju | H.C. Wainwright | $3 | buy | 341.83%Upside | Reiterated | 11/09/26 | ||
| B. Riley Securities | $3 | buy | 341.83%Upside | Initiated | 11/06/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ram SelvarajuH.C. Wainwright | BuyReiterated$3 | 11/09/26 | 341.83%Upside | ||
| BuyInitiated$3 | 11/06/26 | 341.83%Upside |
Best Analysts Covering Cognition Therapeutics
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of +127.70% per trade.
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of +34.22% per trade.
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 23.08% of your transactions generating a profit, with an average return of -3.96% per trade.
CGTX Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 7 | 5 | 3 | 5 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 7 | 5 | 3 | 5 | 6 |
In the current month, CGTX has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGTX average Analyst price target in the past 3 months is 3.00.
CGTX Financial Forecast
CGTX Earnings Forecast
Next quarter’s earnings estimate for CGTX is -$0.05 with a range of -$0.06 to -$0.04. The previous quarter’s EPS was -$0.04. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CGTX Sales Forecast
Next quarter’s sales forecast for CGTX is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

